Needham & Company Starts BioTelemetry (BEAT) at Buy
Get Alerts BEAT Hot Sheet
Price: $0.50 -15.25%
Rating Summary:
8 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Needham & Company analyst Mike Matson initiates coverage on BioTelemetry (NASDAQ: BEAT) with a Buy rating and a price target of $52.00.
For an analyst ratings summary and ratings history on BioTelemetry click here. For more ratings news on BioTelemetry click here.
Shares of BioTelemetry closed at $36.67 yesterday.
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- UBS Starts Schrodinger (SDGR) at Neutral
- Leerink Starts Freenome Inc. (FRNM) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share